India's Ranbaxy Seller Turns To Other Forms Of Healthcare
This article was originally published in PharmAsia News
Executive Summary
The man who sold India's Ranbaxy Laboratories to Daiichi Sankyo is actively engaged in trying to expand the fortunes of Fortis Healthcare